Related Experiment Video
Updated: Mar 20, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
The transcription factor FOXN3 inhibits cell proliferation by downregulating E2F5 expression in hepatocellular
Abstract:
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide, and the mechanisms underlying the development of HCC remain to be elucidated. Forkhead box N3 (FOXN3) is an important member of the FOX family of transcription factors that plays an essential role in several cancers but has not been investigated in HCC. In this study, we demonstrate that FOXN3 is downregulated in human primary HCC tissues compared with their matched adjacent liver tissues. Functional tests of FOXN3 demonstrated that FOXN3 inhibits the proliferation of HCC cells in vitro and in vivo. Additionally, FOXN3 repressed the mRNA and protein expression of E2F5, a reported potential oncogene, by inhibiting the promoter activity of E2F5. Collectively, our findings indicate that FOXN3 functions as a tumor suppressor in HCC by downregulating the expression of E2F5.
Insights
Forkhead box N3 (FOXN3) acts as a tumor suppressor in hepatocellular carcinoma (HCC). This study found FOXN3 inhibits HCC cell growth by reducing the oncogene E2F5 expression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
- The molecular mechanisms driving HCC development require further investigation.
- Forkhead box N3 (FOXN3), a transcription factor, has known roles in various cancers but its function in HCC is unexplored.
Purpose of the Study:
- To investigate the role of FOXN3 in hepatocellular carcinoma.
- To determine the effect of FOXN3 on HCC cell proliferation and the expression of E2F5.
Main Methods:
- Comparison of FOXN3 expression in human HCC tissues and adjacent normal liver tissues.
- In vitro and in vivo functional assays to assess FOXN3's impact on HCC cell proliferation.
- Analysis of FOXN3's effect on E2F5 mRNA, protein expression, and promoter activity.
Main Results:
- FOXN3 expression was found to be downregulated in human primary HCC tissues.
- FOXN3 significantly inhibited HCC cell proliferation both in vitro and in vivo.
- FOXN3 repressed the expression of the potential oncogene E2F5 at both mRNA and protein levels by inhibiting its promoter activity.
Conclusions:
- FOXN3 functions as a tumor suppressor in hepatocellular carcinoma.
- The tumor-suppressive role of FOXN3 in HCC is mediated through the downregulation of E2F5 expression.
Related Concept Videos
Abnormal Proliferation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Negative Regulator Molecules
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Cell Specific Gene Expression
Canonical Wnt Signaling Pathway

